Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000162·Atea Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Atea Pharmaceuticals Inc
Common Stock · CUSIP: 04683R106
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EcoR1 Capital, LLC
Shares: 3,341,653.00 · Class: 4.0%
- Oleg Nodelman
Shares: 3,341,653.00 · Class: 4.0%
- EcoR1 Capital Fund Qualified, L.P.
Shares: 3,156,745.00 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000162
- Form type
- SCHEDULE 13G/A
- Filer
- Atea Pharmaceuticals, Inc.
- CIK
- CIK 1593899
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership